SARCULATOR

Published by: DIGITAL FOREST SRL
Downloads
Revenue

Description

This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.
Two kinds of predictions are possible:
- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
Hide Show More...

Screenshots

SARCULATOR FAQ

  • Is SARCULATOR free?

    Yes, SARCULATOR is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is SARCULATOR legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does SARCULATOR cost?

    SARCULATOR is free.

  • What is SARCULATOR revenue?

    To get estimated revenue of SARCULATOR app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating

5 out of 5

1 ratings in Germany

5 star
1
4 star
0
3 star
0
2 star
0
1 star
0
Ratings History

SARCULATOR Reviews

No Reviews in Germany
App doesn't have any reviews in Germany yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
Chart
Category
Rank
Top Free
404
Top Free
418
Top Free
472

SARCULATOR Competitors

Name
ESMO Events App
HemeOncBuddy
hemeonc trials
ESMO Interactive Guidelines
RO Toolbox
Tempus Provider
Track and view patient results
Physicians Cancer Chemotherapy
Clinical Therapy Drug Guide
ASCO Guidelines
Rad Onc Tables
SSO Mobile
SSO Mobile App
TNM Cancer Staging System
AJCC Licensed Content V9

SARCULATOR Installs

Last 30 days

SARCULATOR Revenue

Last 30 days

SARCULATOR Revenue and Downloads

Gain valuable insights into SARCULATOR performance with our analytics.
Sign up now to access downloads, revenue, and more.